Pathogenetic Impact of Bacterial–Fungal Interactions

Filomena Nogueira; Shirin Sharghi; Karl Kuchler; Thomas Lion

doi:10.3390/microorganisms7100459

journal article Open Access Oct 16, 2019

Pathogenetic Impact of Bacterial–Fungal Interactions

Filomena Nogueira Shirin Sharghi Karl Kuchler

Thomas Lion

Microorganisms Vol. 7 No. 10 pp. 459 · MDPI AG

View at Publisher Save 10.3390/microorganisms7100459

Abstract

Polymicrobial infections are of paramount importance because of the potential severity of clinical manifestations, often associated with increased resistance to antimicrobial treatment. The intricate interplay with the host and the immune system, and the impact on microbiome imbalance, are of importance in this context. The equilibrium of microbiota in the human host is critical for preventing potential dysbiosis and the ensuing development of disease. Bacteria and fungi can communicate via signaling molecules, and produce metabolites and toxins capable of modulating the immune response or altering the efficacy of treatment. Most of the bacterial–fungal interactions described to date focus on the human fungal pathogen Candida albicans and different bacteria. In this review, we discuss more than twenty different bacterial–fungal interactions involving several clinically important human pathogens. The interactions, which can be synergistic or antagonistic, both in vitro and in vivo, are addressed with a focus on the quorum-sensing molecules produced, the response of the immune system, and the impact on clinical outcome.

Topics

No keywords indexed for this article. Browse by subject →

References

230

[1]

Neely "Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes" Infect. Immun. (1986) 10.1128/iai.52.1.200-204.1986

[2]

Bergeron, A.C., Seman, B.G., Hammond, J.H., Archambault, L.S., Hogan, D.A., and Wheeler, R.T. (2017). Candida and Pseudomonas interact to enhance virulence of mucosal infection in transparent zebrafish. Infect. Immun. 10.1128/iai.00475-17

[3]

Kim "Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections" Clin. Microbiol. Infect. (2013) 10.1111/j.1469-0691.2012.03906.x

[4]

Wargo "Fungal--bacterial interactions: a mixed bag of mingling microbes" Curr. Opin. Microbiol. (2006) 10.1016/j.mib.2006.06.001

[5]

Polymicrobial Interactions: Impact on Pathogenesis and Human Disease

Brian M. Peters, Mary Ann Jabra-Rizk, Graeme A. O'May et al.

Clinical Microbiology Reviews 2012 10.1128/cmr.00013-11

[6]

Diaz "Fungal-bacterial interactions and their relevance to oral health: linking the clinic and the bench" Front. Cell. Infect. Microbiol. (2014) 10.3389/fcimb.2014.00101

[7]

Hermann "Bacterial flora accompanying Candida yeasts in clinical specimens" Mycoses (1999) 10.1046/j.1439-0507.1999.00519.x

[8]

Morales, D.K., and Hogan, D.A. (2010). Candida albicans interactions with bacteria in the context of human health and disease. Plos Pathog., 6. 10.1371/journal.ppat.1000886

[9]

Kett "Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study" Crit. Care. Med. (2011) 10.1097/ccm.0b013e318206c1ca

[10]

Thorn "Postmortem Candidemia: Marker of disseminated disease" J. Clin. Pathol. (2010) 10.1136/jcp.2009.070607

[11]

Muhlschlegel "Quorum sensing and fungal-bacterial interactions in Candida albicans: A communicative network regulating microbial coexistence and virulence" Fems Yeast Res. (2009) 10.1111/j.1567-1364.2009.00573.x

[12]

Dixon "Noisy neighbourhoods: quorum sensing in fungal-polymicrobial infections" Cell Microbiol. (2015) 10.1111/cmi.12490

[13]

Braga "Microbial interactions: ecology in a molecular perspective" Braz. J. Microbiol. (2016) 10.1016/j.bjm.2016.10.005

[14]

Fischbach "Microbiome: Focus on Causation and Mechanism" Cell (2018) 10.1016/j.cell.2018.07.038

[15]

Knight "Best practices for analysing microbiomes" Nat. Rev. Microbiol. (2018) 10.1038/s41579-018-0029-9

[16]

Garrett "Cancer and the microbiota" Science (2015) 10.1126/science.aaa4972

[17]

Kruger, W., Vielreicher, S., Kapitan, M., Jacobsen, I.D., and Niemiec, M.J. (2019). Fungal-Bacterial Interactions in Health and Disease. Pathogens, 8. 10.3390/pathogens8020070

[18]

Host–microorganism interactions in lung diseases

Benjamin J. Marsland, Eva S. Gollwitzer

Nature Reviews Immunology 2014 10.1038/nri3769

[19]

Nash "The gut mycobiome of the Human Microbiome Project healthy cohort" Microbiome (2017) 10.1186/s40168-017-0373-4

[20]

Witherden, E.A., Shoaie, S., Hall, R.A., and Moyes, D.L. (2017). The Human Mucosal Mycobiome and Fungal Community Interactions. J. Fungi (Basel), 3. 10.3390/jof3040056

[21]

Jo "Topographical and physiological differences of the skin mycobiome in health and disease" Virulence (2017) 10.1080/21505594.2016.1249093

[22]

Statovci "The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces" Front. Immunol. (2017) 10.3389/fimmu.2017.00838

[23]

Clarke "Minireview: Gut microbiota: the neglected endocrine organ" Mol. Endocrinol. (2014) 10.1210/me.2014-1108

[24]

Role of the Microbiota in Immunity and Inflammation

Yasmine Belkaid, Timothy W. Hand

Cell 2014 10.1016/j.cell.2014.03.011

[25]

Caballero "Microbiota-mediated inflammation and antimicrobial defense in the intestine" Annu. Rev. Immunol. (2015) 10.1146/annurev-immunol-032713-120238

[26]

Rukundo "Human Gut Microbiota: Toward an Ecology of Disease" Front. Microbiol. (2017) 10.3389/fmicb.2017.01265

[27]

Tojo "Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis" World J. Gastroenterol. (2014) 10.3748/wjg.v20.i41.15163

[28]

Candela "Inflammation and colorectal cancer, when microbiota-host mutualism breaks" World J. Gastroenterol. (2014) 10.3748/wjg.v20.i4.908

[29]

Brumlow "Impact of the Microbiota on Bacterial Infections during Cancer Treatment" Trends Microbiol. (2017) 10.1016/j.tim.2017.06.006

[30]

Heisel, T., Montassier, E., Johnson, A., Al-Ghalith, G., Lin, Y.W., Wei, L.N., Knights, D., and Gale, C.A. (2017). High-Fat Diet Changes Fungal Microbiomes and Interkingdom Relationships in the Murine Gut. mSphere, 2. 10.1128/msphere.00351-17

[31]

Lof, M., Janus, M.M., and Krom, B.P. (2017). Metabolic Interactions between Bacteria and Fungi in Commensal Oral Biofilms. J. Fungi (Basel), 3. 10.3390/jof3030040

[32]

Raskov "Linking Gut Microbiota to Colorectal Cancer" J. Cancer (2017) 10.7150/jca.20497

[33]

Tsilimigras "Carcinogenesis and therapeutics: the microbiota perspective" Nat. Microbiol. (2017) 10.1038/nmicrobiol.2017.8

[34]

Zitvogel "Anticancer effects of the microbiome and its products" Nat. Rev. Microbiol. (2017) 10.1038/nrmicro.2017.44

[35]

Schwabe "The microbiome and cancer" Nat. Rev. Cancer (2013) 10.1038/nrc3610

[36]

Liguori "Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn’s Disease Patients" J. Crohns. Colitis. (2016) 10.1093/ecco-jcc/jjv209

[37]

Pope "Microbiota as a mediator of cancer progression and therapy" Transl. Res. (2017) 10.1016/j.trsl.2016.07.021

[38]

Gagniere "Gut microbiota imbalance and colorectal cancer" World J. Gastroenterol. (2016) 10.3748/wjg.v22.i2.501

[39]

DeGruttola "Current Understanding of Dysbiosis in Disease in Human and Animal Models" Inflamm. Bowel Dis. (2016) 10.1097/mib.0000000000000750

[40]

Williams "Gnotobiotics" Proc. Natl. Acad. Sci. USA (2014) 10.1073/pnas.1324049111

[41]

Gordon "The gnotobiotic animal as a tool in the study of host microbial relationships" Bacteriol. Rev. (1971) 10.1128/br.35.4.390-429.1971

[42]

The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice

Peter J. Turnbaugh, Vanessa K. Ridaura, Jeremiah J. Faith et al.

Science Translational Medicine 2009 10.1126/scitranslmed.3000322

[43]

Metagenomic Analysis of the Human Distal Gut Microbiome

Steven R. Gill, Mihai Pop, Robert T. DeBoy et al.

Science 2006 10.1126/science.1124234

[44]

An obesity-associated gut microbiome with increased capacity for energy harvest

Peter J. Turnbaugh, Ruth E. Ley, Michael A. Mahowald et al.

Nature 2006 10.1038/nature05414

[45]

The gut microbiota as an environmental factor that regulates fat storage

Fredrik Bäckhed, Hao Ding, Ting Wang et al.

Proceedings of the National Academy of Sciences 2004 10.1073/pnas.0407076101

[46]

Cash "Symbiotic bacteria direct expression of an intestinal bactericidal lectin" Science (2006) 10.1126/science.1127119

[47]

Umesaki "Use of gnotobiotic mice to identify and characterize key microbes responsible for the development of the intestinal immune system" Proc. Jpn. Acad. Ser. B. (2014) 10.2183/pjab.90.313

[48]

Burmolle "Interactions in multispecies biofilms: do they actually matter?" Trends Microbiol. (2014) 10.1016/j.tim.2013.12.004

[49]

"Microbial biofilms and the human intestinal microbiome" Npj Biofilms Microbiomes (2015) 10.1038/npjbiofilms.2015.5

[50]

Raskov "Bacterial biofilm formation inside colonic crypts may accelerate colorectal carcinogenesis" Clin. Transl. Med. (2018) 10.1186/s40169-018-0209-2

Showing 50 of 230 references

Cited By

41

Fungal endometritis in broodmares: clinical presentation, prevalence in Ireland and diagnostic performance of cytology

Aurore Le Breton, Julie Storme · 2026

Journal of Equine Veterinary Scienc...

Bacterial‐fungal interactions and their impact on microbial pathogenesis

Jessie MacAlpine, Nicole Robbins · 2022

Molecular Ecology

Metrics

41

Citations

230

References

Details

Published: Oct 16, 2019
Vol/Issue: 7(10)
Pages: 459
License: View

Authors

F

Filomena Nogueira

CCRI—St. Anna Children’s Cancer Research Institute, Vienna 1090, Austria; Labdia—Labordiagnostik GmbH, Vienna 1090, Austria; Center of Medical Biochemistry, Max Perutz Labs, Campus Vienna Biocenter, Medical University of Vienna, Vienna 1030, Austria

S

Shirin Sharghi

CCRI—St. Anna Children’s Cancer Research Institute, Vienna 1090, Austria; Labdia—Labordiagnostik GmbH, Vienna 1090, Austria; Center of Medical Biochemistry, Max Perutz Labs, Campus Vienna Biocenter, Medical University of Vienna, Vienna 1030, Austria

K

Karl Kuchler

Center of Medical Biochemistry, Max Perutz Labs, Campus Vienna Biocenter, Medical University of Vienna, Vienna 1030, Austria

T

Thomas Lion

CCRI—St. Anna Children’s Cancer Research Institute, Vienna 1090, Austria; Labdia—Labordiagnostik GmbH, Vienna 1090, Austria; Department of Pediatrics, Medical University of Vienna, Vienna 1090, Austria

Funding

FP7 Framework Programme Award: 602125

Cite This Article

Filomena Nogueira, Shirin Sharghi, Karl Kuchler, et al. (2019). Pathogenetic Impact of Bacterial–Fungal Interactions. Microorganisms, 7(10), 459. https://doi.org/10.3390/microorganisms7100459

Pathogenetic Impact of Bacterial–Fungal Interactions

You May Also Like